SIGA TECHNOLOGIES INC
SIGA · XNASCIK 1010086fmd_0S2MENA5R7NJY44XB1QZ2D69G8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 15 | 12 | 477 | 27 | 125 | 134 | 111 | 140 | 139 | 95 |
| Cost of revenue | 0 | 0 | 95 | 2 | 15 | 17 | 10 | 18 | 31 | 30 |
| Gross profit | 15 | 12 | 382 | 25 | 110 | 117 | 100 | 122 | 107 | 65 |
| Research and development | 20 | 17 | 13 | 13 | 11 | 10 | 23 | 16 | 12 | 20 |
| Selling, general and administrative | 14 | 12 | 13 | 13 | 15 | 18 | 35 | 22 | 25 | 21 |
| Total operating expenses | 46 | 31 | 122 | 29 | – | – | – | – | – | – |
| Operating income | (31) | (19) | 355 | (2) | 85 | 89 | 43 | 84 | 70 | 24 |
| Interest expense | 2 | 15 | 15 | 16 | 3 | 0 | 0 | – | – | – |
| Other non-operating income (expense) | 0 | 0 | 79 | 3 | 1 | 0 | 1 | 4 | 6 | 7 |
| Income before taxes | (40) | (38) | 412 | (10) | 74 | 89 | 44 | 88 | 76 | 30 |
| Income tax expense | 0 | (2) | (10) | (3) | 17 | 20 | 10 | 20 | 17 | 7 |
| Net income from continuing operations | (40) | (36) | 422 | (7) | 56 | 69 | 34 | 68 | 59 | 23 |
| Net income | (40) | (36) | 422 | (7) | 56 | 69 | 34 | 68 | 59 | 23 |